Potential Risk of Hypoglycemia in Patients with Heart Failure.

The properties of glucose changes in patients with chronic heart failure remain elusive. In the present study, we investigated the sequential changes of interstitial glucose concentrations in patients with chronic heart failure and heart disease who were not undergoing antidiabetic therapy.A glucose monitoring device (FreeStyle Libre Pro) was attached to the backside of an upper arm and the interstitial glucose concentration was monitored every 15 minutes for 1 week. Eleven patients with chronic heart failure (Heart failure (+) ) and 7 patients with chronic heart diseases but not with heart failure (Heart failure (-) ) were enrolled. The average level and peak value of interstitial glucose concentrations, and the duration of hyperglycemia (≥ 140 mg/dL) were not significantly different between Heart failure (+) and Heart failure (-). The duration of hypoglycemia (< 80 mg/dL) was significantly longer and the trough value was significantly lower in Heart failure (+) compared with Heart failure (-). Most of the patients in Heart failure (+) were exposed to a long duration of hypoglycemia from midnight to morning. Importantly, none of the patients who showed hypoglycemia complained of any subjective symptoms during hypoglycemia. Malabsorption may be one of the mechanisms of hypoglycemia.In summary, patients with chronic heart failure are at risk of developing hypoglycemia even if they do not undergo any antidiabetic therapy.

Preparation of a magnetic metal-organic square and metal-organic cubes using 4,5-bis(2-imidazolinyl)imidazolate: slow magnetization relaxation behavior in mixed-valent octamanganese(ii/iii) clusters.

Functional metal-organic squares (MOSs) and metal-organic cubes (MOCs) are important building units for zeolite-like metal-organic frameworks (ZMOFs), which are required to exhibit solid-state properties, such as dielectric, conductive, and magnetic properties. This work describes the preparation and magnetism of a tetracopper(ii) macrocyclic complex [CuII4(im-H2bizn)4(DMSO)3(THF)](ClO4)4·8DMSO (1) (Him-H2bizn = 4,5-bis(4,5-dihydro-1H-imidazol-2-yl)imidazole) as a MOS and octametallic clusters [NiII8(im-H2bizn)12](ClO4)4·10MeOH·3H2O (2) and [MnII4MnIII4(im-H2bizn)12](ClO4)8·14MeOH (3) as MOCs. The CuII ion in 1 possesses a five-coordinated square pyramidal geometry, resulting in the formation of an M4L4-type square, which gives an estimated intramolecular antiferromagnetic interaction with an exchange coupling constant of JCu-Cu = -95 K. Meanwhile, 2 and 3 present six-coordinated octahedral geometries, giving M8L12-type cubes, of which 2 is a normal paramagnetic compound with intramolecular antiferromagnetic interactions, and where JNi-Ni = -32 K. The most notable compound 3 is a MnII4MnIII4 mixed valence state compound, which exhibits a slow magnetization relaxation behavior similar to that of single-molecule magnets. This is attributed to the contribution of magnetic anisotropy caused by the Jahn-Teller effect of the MnIII ions. Utilizing a modified Arrhenius plot to extract the values of the thermal barrier for magnetization reversal (Ea/kB) and the pre-exponential factor (τ0), the parameters for the relaxation behavior were estimated to be Ea/kB = 6.38 K and τ0 = 3.87 × 10-7 s. UV-vis spectroscopy and electrochemical measurements in solution were also carried out. Compound 3 will be expected to lead to a solid-state material in which the magnetic and dielectric properties of encapsulated small molecules cooperate with the slow magnetization relaxation properties of the MOC backbone.